Teva gets a buy rating as it trades well below 10-year highs and shows growth potential as the leading global generic drugmaker. Their drug pipeline is robust and diverse, as well as existing ...

Teva Pharmaceutical Industries (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) said the FDA has expanded labeling for its biosimilar of Johnson & Johnson’s (JNJ) Stelara to include the treatment of Crohn ...

Barclays raised the firm’s price target on Teva (TEVA) to $25 from $22 and keeps an Overweight rating on the shares. The firm introduced Olanzapine into its model, noting TEV-749’s sales ...

In the latest quarter, 4 analysts provided ratings for Teva Pharmaceutical Indus TEVA, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ...

Shares of Teva Pharmaceutical Industries Ltd. (TEVA) have gained 2.9% over the past four weeks to close the last trading session at $18.25, but there could still be a solid upside left in the ...

Teva Zaveroni hails the performances of rising star Heimanu Terorotua at the OFC Beach Soccer Nations Cup and backs Tahiti to shine at Seychelles 2025. Not many people know that Teva Zaveroni, the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The former chair of the Florida Republican Party, Al Cardenas, says he's voting for Kamala Harris for president on Nov. 5. Cardenas spoke to Telemundo 51’s Gloria Ordaz alongside Nikki Fried ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.